EIDP, Inc. (CTA-PA) 10-Year Financial Performance & Capital Metrics

CTA-PA • • Industrial / General

Basic MaterialsAgricultural InputsSeed & BiotechnologySeed Technology & Traits

AboutEIDP, Inc. engages in the provision of science-based products and services. It operates through the Seed and Crop Protection segments. The Seed segment develops and supplies advanced germplasm and traits that produce optimum yield for farms around the world. The Crop Protection segment serves the global agricultural input industry with products that protect against weeds, insects and other pests, and disease, and that improve overall crop health both above and below ground via nitrogen management and seed-applied technologies. The company was founded by Eleuthere Irenee du Pont in 1802 and is headquartered in Indianapolis, IN.Show more

Revenue $16.91B -1.8%
EBITDA $3.32B
Net Income $907M +23.4%
EPS (Diluted) 1.30 +54.8%
Gross Margin 43.64% +2.9%
EBITDA Margin 19.65% +1.9%
Operating Margin 12.4% +1.2%
Net Margin 5.36% +25.7%
ROE 3.68% +27.2%
ROIC 6.45% -0.6%
Debt/Equity 0.11 +14.2%
Interest Coverage 9.00 -0.7%

Technical Analysis

Key Insights

Based on financial data analysis

✓Strengths

✓Strong Piotroski F-Score: 7/9
✓High quality earnings: Operating CF exceeds net income

✗Weaknesses

✗Weak 3Y average ROE of 3.7%

Price & Volume

Loading chart...

Growth Metrics

Revenue CAGR

10Y-

5Y4.08%

3Y2.6%

TTM5%

Profit (Net Income) CAGR

10Y-

5Y-

3Y-19.81%

TTM131.22%

EPS CAGR

10Y-

5Y-

3Y-

TTM93.62%

ROCE

10Y Avg3.6%

5Y Avg5.11%

3Y Avg6.39%

Latest6.65%

Peer Comparison

Seed Technology & Traits

Name	Market Cap	Current Price	P/E Ratio	Revenue Growth 1Y	Net Margin	ROE	FCF Yield	Debt/Equity
CTVACorteva, Inc.	47.64B	70.50	54.23	-1.85%	9.19%	6.3%	3.25%	0.11
CTA-PAEIDP, Inc.	47.43B	54.65	42.04	-1.85%	9.2%	6.4%	3.26%	0.11
RKDAArcadia Biosciences, Inc.	5.24M	2.40	-0.47	13.27%	-97.95%	-93.09%		0.02

Profit & Loss

	Dec 2016	Dec 2017	Dec 2018	Dec 2019	Dec 2020	Dec 2021	Dec 2022	Dec 2023	Dec 2024
Sales/Revenue+	14.04B	14.24B	14.29B	13.85B	14.22B	15.65B	17.45B	17.23B	16.91B
Revenue Growth %	-	0.01%	0%	-0.03%	0.03%	0.1%	0.11%	-0.01%	-0.02%
Cost of Goods Sold+	8.39B	8.4B	8.52B	8.57B	8.51B	9.22B	10.44B	9.92B	9.53B
COGS % of Revenue	0.6%	0.59%	0.6%	0.62%	0.6%	0.59%	0.6%	0.58%	0.56%
Gross Profit+	5.65B	5.84B	5.77B	5.27B	5.71B	6.43B	7.02B	7.31B	7.38B
Gross Margin %	0.4%	0.41%	0.4%	0.38%	0.4%	0.41%	0.4%	0.42%	0.44%
Gross Profit Growth %	-	0.03%	-0.01%	-0.09%	0.08%	0.13%	0.09%	0.04%	0.01%
Operating Expenses+	4.76B	5.65B	4.48B	4.69B	4.87B	5.12B	5.09B	5.2B	5.28B
OpEx % of Revenue	0.34%	0.4%	0.31%	0.34%	0.34%	0.33%	0.29%	0.3%	0.31%
Selling, General & Admin	2.94B	2.97B	2.9B	3.06B	3.04B	3.21B	3.17B	3.18B	3.2B
SG&A % of Revenue	0.21%	0.21%	0.2%	0.22%	0.21%	0.2%	0.18%	0.18%	0.19%
Research & Development	1.51B	1.51B	1.43B	1.15B	1.14B	1.19B	1.22B	1.34B	1.4B
R&D % of Revenue	0.11%	0.11%	0.1%	0.08%	0.08%	0.08%	0.07%	0.08%	0.08%
Other Operating Expenses	320M	1.17B	142M	475M	682M	722M	702M	683M	685M
Operating Income+	886M	188M	1.29B	584M	843M	1.32B	1.93B	2.11B	2.1B
Operating Margin %	0.06%	0.01%	0.09%	0.04%	0.06%	0.08%	0.11%	0.12%	0.12%
Operating Income Growth %	-	-0.79%	5.86%	-0.55%	0.44%	0.56%	0.46%	0.09%	-0.01%
EBITDA+	2.14B	1.75B	2.2B	2.18B	2.02B	2.56B	3.15B	3.32B	3.32B
EBITDA Margin %	0.15%	0.12%	0.15%	0.16%	0.14%	0.16%	0.18%	0.19%	0.2%
EBITDA Growth %	-	-0.18%	0.26%	-0.01%	-0.07%	0.27%	0.23%	0.05%	0%
D&A (Non-Cash Add-back)	1.26B	1.56B	909M	1.6B	1.18B	1.24B	1.22B	1.21B	1.23B
EBIT	3.09B	-300M	-6.47B	-180M	720M	2.38B	1.5B	1.33B	1.51B
Net Interest Income+	-101M	-74M	-251M	-77M	11M	47M	45M	50M	-101M
Interest Income	0	0	80M	59M	56M	77M	124M	283M	132M
Interest Expense	101M	74M	76M	136M	45M	30M	79M	233M	233M
Other Income/Expense	-628M	17M	-6.36B	-900M	-168M	1.03B	-502M	-1.02B	-821M
Pretax Income+	258M	-374M	-4.55B	-316M	675M	2.35B	1.43B	1.09B	1.27B
Pretax Margin %	0.02%	-0.03%	-0.32%	-0.02%	0.05%	0.15%	0.08%	0.06%	0.08%
Income Tax+	-270M	-2.94B	408M	-46M	-81M	524M	210M	152M	412M
Effective Tax Rate %	1.95%	-6.78%	1.1%	3.03%	1.01%	0.75%	0.8%	0.67%	0.71%
Net Income+	503M	2.53B	-4.99B	-959M	681M	1.76B	1.15B	735M	907M
Net Margin %	0.04%	0.18%	-0.35%	-0.07%	0.05%	0.11%	0.07%	0.04%	0.05%
Net Income Growth %	-	4.04%	-2.97%	0.81%	1.71%	1.58%	-0.35%	-0.36%	0.23%
Net Income (Continuing)	528M	2.57B	-6.78B	-270M	756M	1.82B	1.22B	941M	863M
Discontinued Operations	0	0	0	-671M	-55M	-53M	-58M	-194M	56M
Minority Interest	198M	172M	265M	246M	239M	239M	239M	242M	241M
EPS (Diluted)+	0.58	2.92	-5.75	0.00	0.00	0.00	0.00	0.84	1.30
EPS Growth %	-	4.03%	-2.97%	1%	-	-	-	-	0.55%
EPS (Basic)	0.58	2.92	-5.75	0.00	0.00	0.00	0.00	0.84	1.31
Diluted Shares Outstanding	867.81M	867.81M	867.81M	0	0	0	0	867.81M	867.81M
Basic Shares Outstanding	867.81M	867.81M	867.81M	0	0	0	0	867.81M	867.81M
Dividend Payout Ratio	2.65%	0.39%	-	-	0.57%	0.23%	0.36%	0.6%	0.5%

Balance Sheet

	Dec 2016	Dec 2017	Dec 2018	Dec 2019	Dec 2020	Dec 2021	Dec 2022	Dec 2023	Dec 2024
Total Current Assets+	17.51B	23.05B	13.84B	13.52B	14.77B	15.55B	16.8B	16.26B	15.1B
Cash & Short-Term Investments	5.91B	8.76B	2.13B	1.77B	3.79B	4.54B	3.31B	2.74B	3.17B
Cash Only	4.55B	7.81B	2.13B	1.76B	3.53B	4.46B	3.19B	2.64B	3.11B
Short-Term Investments	1.36B	952M	5M	5M	269M	86M	124M	98M	63M
Accounts Receivable	4.96B	5.24B	5.26B	5.53B	4.93B	4.81B	5.7B	5.49B	5.68B
Days Sales Outstanding	128.91	134.29	134.38	145.73	126.47	112.17	119.21	116.28	122.53
Inventory	5.35B	8.63B	5.25B	5.03B	4.88B	5.18B	6.81B	6.9B	5.43B
Days Inventory Outstanding	232.72	375.04	224.89	214.19	209.47	205.07	238.22	253.84	208.07
Other Current Assets	788M	423M	9.41B	1.19B	1.17B	1.01B	968M	1.13B	820M
Total Non-Current Assets+	22.45B	89.91B	29.04B	28.88B	27.88B	26.8B	25.82B	26.74B	25.73B
Property, Plant & Equipment	8.85B	12.44B	4.53B	4.55B	4.4B	4.33B	4.25B	4.29B	4.1B
Fixed Asset Turnover	1.59x	1.15x	3.15x	3.05x	3.23x	3.62x	4.10x	4.02x	4.12x
Goodwill	4.17B	45.59B	10.19B	10.23B	10.27B	10.11B	9.96B	10.61B	10.41B
Intangible Assets	0	27.73B	12.05B	11.42B	10.75B	10.04B	9.34B	9.63B	8.88B
Long-Term Investments	649M	1.59B	138M	66M	66M	76M	102M	115M	134M
Other Non-Current Assets	5.47B	2.08B	1.83B	2.33B	1.94B	1.8B	1.69B	1.52B	1.81B
Total Assets+	39.96B	112.96B	42.88B	42.4B	42.65B	42.34B	42.62B	43B	40.83B
Asset Turnover	0.35x	0.13x	0.33x	0.33x	0.33x	0.37x	0.41x	0.40x	0.41x
Asset Growth %	-	1.83%	-0.62%	-0.01%	0.01%	-0.01%	0.01%	0.01%	-0.05%
Total Current Liabilities+	8.93B	12.14B	9.99B	8.24B	8.55B	9.56B	10.74B	10.41B	10.39B
Accounts Payable	3.68B	4.83B	3.8B	3.7B	3.62B	4.13B	4.89B	4.28B	4.04B
Days Payables Outstanding	159.99	209.87	162.69	157.58	155.1	163.34	171.2	157.48	154.71
Short-Term Debt	429M	2.78B	2.13B	3M	3M	17M	23M	197M	750M
Deferred Revenue (Current)	1000K	1000K	1000K	1000K	1000K	1000K	1000K	1000K	1000K
Other Current Liabilities	2.61B	2.52B	985M	-2.58B	-1M	0	0	0	0
Current Ratio	1.96x	1.90x	1.38x	1.64x	1.73x	1.63x	1.56x	1.56x	1.45x
Quick Ratio	1.36x	1.19x	0.86x	1.03x	1.16x	1.08x	0.93x	0.90x	0.93x
Cash Conversion Cycle	201.64	299.45	196.58	202.34	180.83	153.9	186.23	212.65	175.89
Total Non-Current Liabilities+	20.84B	25.89B	9.06B	9.6B	9.04B	7.16B	6.33B	7.31B	6.41B
Long-Term Debt	8.1B	10.29B	5.72B	115M	1.1B	1.1B	1.28B	2.29B	1.95B
Capital Lease Obligations	9M	4M	67M	5M	0	3M	2M	0	0
Deferred Tax Liabilities	425M	5.84B	1.5B	920M	893M	1.22B	1.12B	899M	478M
Other Non-Current Liabilities	12.3B	9.71B	1.63B	8.56B	7.04B	4.84B	2.81B	4.12B	3.98B
Total Liabilities	29.77B	38.03B	19.06B	17.84B	17.59B	16.72B	17.08B	17.72B	16.8B
Total Debt+	8.54B	13.07B	2.07B	127M	1.11B	1.12B	1.31B	2.49B	2.7B
Net Debt	3.99B	5.26B	-60M	-1.64B	-2.42B	-3.34B	-1.88B	-155M	-403M
Debt / Equity	0.84x	0.17x	0.09x	0.01x	0.04x	0.04x	0.05x	0.10x	0.11x
Debt / EBITDA	3.98x	7.46x	0.94x	0.06x	0.55x	0.44x	0.41x	0.75x	0.81x
Net Debt / EBITDA	1.86x	3.00x	-0.03x	-0.75x	-1.20x	-1.30x	-0.60x	-0.05x	-0.12x
Interest Coverage	8.77x	2.54x	16.97x	4.29x	18.73x	43.90x	24.41x	9.06x	9.00x
Total Equity+	10.2B	74.93B	23.82B	24.55B	25.06B	25.62B	25.54B	25.28B	24.03B
Equity Growth %	-	6.35%	-0.68%	0.03%	0.02%	0.02%	-0%	-0.01%	-0.05%
Book Value per Share	11.75	86.35	27.45	999999.00	33.71	999999.00	999999.00	29.13	27.69
Total Shareholders' Equity	10B	74.76B	23.56B	24.31B	24.82B	25.38B	25.3B	25.04B	23.79B
Common Stock	285M	0	7M	7M	7M	7M	7M	7M	7M
Retained Earnings	14.92B	175M	-1M	-425M	0	524M	250M	-41M	55M
Treasury Stock	-6.73B	0	0	0	0	0	0	0	0
Accumulated OCI	-16.98B	-381M	-2.41B	-3.27B	-2.89B	-2.9B	-2.81B	-2.68B	-3.47B
Minority Interest	198M	172M	265M	246M	239M	239M	239M	242M	241M

Cash Flow

	Dec 2016	Dec 2017	Dec 2018	Dec 2019	Dec 2020	Dec 2021	Dec 2022	Dec 2023	Dec 2024
Cash from Operations+	3.36B	247M	483M	1.07B	2.06B	2.73B	872M	1.77B	2.15B
Operating CF Margin %	0.24%	0.02%	0.03%	0.08%	0.15%	0.17%	0.05%	0.1%	0.13%
Operating CF Growth %	-	-0.93%	0.96%	1.22%	0.93%	0.32%	-0.68%	1.03%	0.21%
Net Income	2.07B	2.71B	-5.03B	-941M	701M	1.82B	1.22B	924M	863M
Depreciation & Amortization	1.26B	1.56B	2.79B	1.6B	1.18B	1.24B	1.22B	1.21B	1.23B
Stock-Based Compensation	0	0	0	0	0	0	0	0	0
Deferred Taxes	0	-3.02B	31M	-477M	-330M	199M	-288M	-438M	-365M
Other Non-Cash Items	4.62B	4.7B	1.38B	1.33B	19M	-1.16B	286M	858M	500M
Working Capital Changes	-1.07B	-583M	-2.94B	-441M	497M	622M	-1.56B	-786M	-80M
Change in Receivables	-270M	-162M	-1.52B	-361M	187M	-113M	-993M	358M	-705M
Change in Inventory	-54M	-1.21B	-498M	74M	104M	-422M	-1.72B	57M	1.11B
Change in Payables	-674M	-621M	642M	149M	-118M	526M	807M	-663M	-115M
Cash from Investing+	-1.51B	386M	-505M	-904M	-674M	-362M	-632M	-1.99B	-589M
Capital Expenditures	-1.02B	-1.11B	-1.5B	-1.16B	-475M	-573M	-605M	-595M	-597M
CapEx % of Revenue	0.07%	0.08%	0.11%	0.08%	0.03%	0.04%	0.03%	0.03%	0.04%
Acquisitions	-	-	-	-	-	-	-	-	-
Investments	-	-	-	-	-	-	-	-	-
Other Investing	-340M	-214M	66M	236M	76M	74M	34M	23M	-27M
Cash from Financing+	-2.38B	2.4B	-2.62B	-2.93B	303M	-1.27B	-1.18B	-99M	-1.2B
Debt Issued (Net)	-	-	-	-	-	-	-	-	-
Equity Issued (Net)	-	-	-	-	-	-	-	-	-
Dividends Paid	-1.33B	-998M	-10M	-511M	-388M	-397M	-418M	-439M	-458M
Share Repurchases	-	-	-	-	-	-	-	-	-
Other Financing	-48M	-893M	0	5.28B	-32M	70M	33M	771M	28M
Net Change in Cash	-	-	-	-	-	-	-	-	-
Free Cash Flow+	2.34B	-866M	-1.02B	-93M	1.59B	2.15B	267M	1.17B	1.55B
FCF Margin %	0.17%	-0.06%	-0.07%	-0.01%	0.11%	0.14%	0.02%	0.07%	0.09%
FCF Growth %	-	-1.37%	-0.18%	0.91%	18.09%	0.36%	-0.88%	3.4%	0.32%
FCF per Share	2.69	-1.00	-1.17	-465000.00	2.14	999999.00	999999.00	1.35	1.78
FCF Conversion (FCF/Net Income)	6.67x	0.10x	-0.10x	-1.12x	3.03x	1.55x	0.76x	2.41x	2.36x
Interest Paid	0	0	923M	263M	36M	30M	75M	234M	244M
Taxes Paid	0	0	961M	234M	229M	341M	467M	535M	707M

Key Ratios

Metric	2016	2017	2018	2019	2020	2021	2022	2023	2024
Return on Equity (ROE)	4.93%	5.95%	-10.11%	-3.96%	2.74%	6.94%	4.48%	2.89%	3.68%
Return on Invested Capital (ROIC)	4.68%	0.3%	1.86%	1.88%	2.78%	4.4%	6.3%	6.49%	6.45%
Gross Margin	40.24%	41%	40.36%	38.07%	40.16%	41.11%	40.21%	42.41%	43.64%
Net Margin	3.58%	17.79%	-34.93%	-6.93%	4.79%	11.24%	6.57%	4.27%	5.36%
Debt / Equity	0.84x	0.17x	0.09x	0.01x	0.04x	0.04x	0.05x	0.10x	0.11x
Interest Coverage	8.77x	2.54x	16.97x	4.29x	18.73x	43.90x	24.41x	9.06x	9.00x
FCF Conversion	6.67x	0.10x	-0.10x	-1.12x	3.03x	1.55x	0.76x	2.41x	2.36x
Revenue Growth	-	1.42%	0.33%	-3.09%	2.68%	10.11%	11.5%	-1.31%	-1.85%

Revenue by Segment

	2012	2019	2020	2021	2022	2023	2024
Seed	-	7.59B	7.76B	8.4B	5.96B	6.45B	6.5B
Seed Growth	-	-	2.19%	8.33%	-29.12%	8.26%	0.76%
Crop Protection	-	6.26B	6.46B	7.25B	4.59B	4.03B	3.6B
Crop Protection Growth	-	-	3.28%	12.26%	-36.70%	-12.13%	-10.78%
Pharmaceuticals	-	-	-	-	-	-	-
Pharmaceuticals Growth	-	-	-	-	-	-	-

Revenue by Geography

	2012	2019	2020	2021	2022	2023	2024
Seed	-	-	-	-	5.96B	6.45B	6.5B
Seed Growth	-	-	-	-	-	8.26%	0.76%
Latin America	4.55B	2.89B	2.81B	3.54B	-	-	-
Latin America Growth	-	-36.46%	-2.91%	26.38%	-	-	-
EMEA	-	2.74B	2.84B	3.12B	-	-	-
EMEA Growth	-	-	3.72%	9.89%	-	-	-
Asia Pacific	8.03B	1.29B	1.4B	1.45B	-	-	-
Asia Pacific Growth	-	-83.97%	8.85%	3.50%	-	-	-
UNITED STATES	-	6.25B	-	-	-	-	-
UNITED STATES Growth	-	-	-	-	-	-	-
CANADA	-	674M	-	-	-	-	-
CANADA Growth	-	-	-	-	-	-	-
United States	13.28B	-	-	-	-	-	-
United States Growth	-	-	-	-	-	-	-
Europe, Middle East, and Africa	8.03B	-	-	-	-	-	-
Europe, Middle East, and Africa Growth	-	-	-	-	-	-	-
Europe, Middle East, and Africa, Other	3.17B	-	-	-	-	-	-
Europe, Middle East, and Africa, Other Growth	-	-	-	-	-	-	-
China Hong Kong	2.94B	-	-	-	-	-	-
China Hong Kong Growth	-	-	-	-	-	-	-
Brazil	2.36B	-	-	-	-	-	-
Brazil Growth	-	-	-	-	-	-	-
Japan	1.58B	-	-	-	-	-	-
Japan Growth	-	-	-	-	-	-	-
Germany	1.31B	-	-	-	-	-	-
Germany Growth	-	-	-	-	-	-	-
Mexico	1.05B	-	-	-	-	-	-
Mexico Growth	-	-	-	-	-	-	-
Canada	921M	-	-	-	-	-	-
Canada Growth	-	-	-	-	-	-	-
France	765M	-	-	-	-	-	-
France Growth	-	-	-	-	-	-	-
Italy	764M	-	-	-	-	-	-
Italy Growth	-	-	-	-	-	-	-
India	748M	-	-	-	-	-	-
India Growth	-	-	-	-	-	-	-
Latin America, Other	731M	-	-	-	-	-	-
Latin America, Other Growth	-	-	-	-	-	-	-
Asia Pacific, Other	666M	-	-	-	-	-	-
Asia Pacific, Other Growth	-	-	-	-	-	-	-
Korea	662M	-	-	-	-	-	-
Korea Growth	-	-	-	-	-	-	-
Taiwan	594M	-	-	-	-	-	-
Taiwan Growth	-	-	-	-	-	-	-
Argentina	406M	-	-	-	-	-	-
Argentina Growth	-	-	-	-	-	-	-
Russia	376M	-	-	-	-	-	-
Russia Growth	-	-	-	-	-	-	-
Spain	326M	-	-	-	-	-	-
Spain Growth	-	-	-	-	-	-	-
Thailand	324M	-	-	-	-	-	-
Thailand Growth	-	-	-	-	-	-	-
The Netherlands	312M	-	-	-	-	-	-
The Netherlands Growth	-	-	-	-	-	-	-
Australia	261M	-	-	-	-	-	-
Australia Growth	-	-	-	-	-	-	-
Belgium	217M	-	-	-	-	-	-
Belgium Growth	-	-	-	-	-	-	-
Singapore	147M	-	-	-	-	-	-
Singapore Growth	-	-	-	-	-	-	-
Malaysia	110M	-	-	-	-	-	-
Malaysia Growth	-	-	-	-	-	-	-
Denmark	95M	-	-	-	-	-	-
Denmark Growth	-	-	-	-	-	-	-
Luxembourg	77M	-	-	-	-	-	-
Luxembourg Growth	-	-	-	-	-	-	-

Frequently Asked Questions

Valuation & Price

EIDP, Inc. (CTA-PA) has a price-to-earnings (P/E) ratio of 42.0x. This suggests investors expect higher future growth.

Growth & Financials

EIDP, Inc. (CTA-PA) reported $17.47B in revenue for fiscal year 2024. This represents a 24% increase from $14.04B in 2016.

EIDP, Inc. (CTA-PA) saw revenue decline by 1.8% over the past year.

Yes, EIDP, Inc. (CTA-PA) is profitable, generating $1.61B in net income for fiscal year 2024 (5.4% net margin).

Dividend & Returns

Yes, EIDP, Inc. (CTA-PA) pays a dividend with a yield of 0.97%. This makes it attractive for income-focused investors.

EIDP, Inc. (CTA-PA) has a return on equity (ROE) of 3.7%. This is below average, suggesting room for improvement.

EIDP, Inc. (CTA-PA) generated $3.80B in free cash flow for fiscal year 2024. Positive FCF indicates the company can fund dividends, buybacks, or reinvestment.

US Stock Screener

...

EIDP, Inc. (CTA-PA) 10-Year Financial Performance & Capital Metrics

CTA-PA • • Industrial / General

Basic MaterialsAgricultural InputsSeed & BiotechnologySeed Technology & Traits

Revenue $16.91B -1.8%
EBITDA $3.32B
Net Income $907M +23.4%
EPS (Diluted) 1.30 +54.8%
Gross Margin 43.64% +2.9%
EBITDA Margin 19.65% +1.9%
Operating Margin 12.4% +1.2%
Net Margin 5.36% +25.7%
ROE 3.68% +27.2%
ROIC 6.45% -0.6%
Debt/Equity 0.11 +14.2%
Interest Coverage 9.00 -0.7%

Technical Analysis

Key Insights

Based on financial data analysis

✓Strengths

✓Strong Piotroski F-Score: 7/9
✓High quality earnings: Operating CF exceeds net income

✗Weaknesses

✗Weak 3Y average ROE of 3.7%

Price & Volume

Loading chart...

Growth Metrics

Revenue CAGR

10Y-

5Y4.08%

3Y2.6%

TTM5%

Profit (Net Income) CAGR

10Y-

5Y-

3Y-19.81%

TTM131.22%

EPS CAGR

10Y-

5Y-

3Y-

TTM93.62%

ROCE

10Y Avg3.6%

5Y Avg5.11%

3Y Avg6.39%

Latest6.65%

Peer Comparison

Seed Technology & Traits

Name	Market Cap	Current Price	P/E Ratio	Revenue Growth 1Y	Net Margin	ROE	FCF Yield	Debt/Equity
CTVACorteva, Inc.	47.64B	70.50	54.23	-1.85%	9.19%	6.3%	3.25%	0.11
CTA-PAEIDP, Inc.	47.43B	54.65	42.04	-1.85%	9.2%	6.4%	3.26%	0.11
RKDAArcadia Biosciences, Inc.	5.24M	2.40	-0.47	13.27%	-97.95%	-93.09%		0.02

Profit & Loss

	Dec 2016	Dec 2017	Dec 2018	Dec 2019	Dec 2020	Dec 2021	Dec 2022	Dec 2023	Dec 2024
Sales/Revenue+	14.04B	14.24B	14.29B	13.85B	14.22B	15.65B	17.45B	17.23B	16.91B
Revenue Growth %	-	0.01%	0%	-0.03%	0.03%	0.1%	0.11%	-0.01%	-0.02%
Cost of Goods Sold+	8.39B	8.4B	8.52B	8.57B	8.51B	9.22B	10.44B	9.92B	9.53B
COGS % of Revenue	0.6%	0.59%	0.6%	0.62%	0.6%	0.59%	0.6%	0.58%	0.56%
Gross Profit+	5.65B	5.84B	5.77B	5.27B	5.71B	6.43B	7.02B	7.31B	7.38B
Gross Margin %	0.4%	0.41%	0.4%	0.38%	0.4%	0.41%	0.4%	0.42%	0.44%
Gross Profit Growth %	-	0.03%	-0.01%	-0.09%	0.08%	0.13%	0.09%	0.04%	0.01%
Operating Expenses+	4.76B	5.65B	4.48B	4.69B	4.87B	5.12B	5.09B	5.2B	5.28B
OpEx % of Revenue	0.34%	0.4%	0.31%	0.34%	0.34%	0.33%	0.29%	0.3%	0.31%
Selling, General & Admin	2.94B	2.97B	2.9B	3.06B	3.04B	3.21B	3.17B	3.18B	3.2B
SG&A % of Revenue	0.21%	0.21%	0.2%	0.22%	0.21%	0.2%	0.18%	0.18%	0.19%
Research & Development	1.51B	1.51B	1.43B	1.15B	1.14B	1.19B	1.22B	1.34B	1.4B
R&D % of Revenue	0.11%	0.11%	0.1%	0.08%	0.08%	0.08%	0.07%	0.08%	0.08%
Other Operating Expenses	320M	1.17B	142M	475M	682M	722M	702M	683M	685M
Operating Income+	886M	188M	1.29B	584M	843M	1.32B	1.93B	2.11B	2.1B
Operating Margin %	0.06%	0.01%	0.09%	0.04%	0.06%	0.08%	0.11%	0.12%	0.12%
Operating Income Growth %	-	-0.79%	5.86%	-0.55%	0.44%	0.56%	0.46%	0.09%	-0.01%
EBITDA+	2.14B	1.75B	2.2B	2.18B	2.02B	2.56B	3.15B	3.32B	3.32B
EBITDA Margin %	0.15%	0.12%	0.15%	0.16%	0.14%	0.16%	0.18%	0.19%	0.2%
EBITDA Growth %	-	-0.18%	0.26%	-0.01%	-0.07%	0.27%	0.23%	0.05%	0%
D&A (Non-Cash Add-back)	1.26B	1.56B	909M	1.6B	1.18B	1.24B	1.22B	1.21B	1.23B
EBIT	3.09B	-300M	-6.47B	-180M	720M	2.38B	1.5B	1.33B	1.51B
Net Interest Income+	-101M	-74M	-251M	-77M	11M	47M	45M	50M	-101M
Interest Income	0	0	80M	59M	56M	77M	124M	283M	132M
Interest Expense	101M	74M	76M	136M	45M	30M	79M	233M	233M
Other Income/Expense	-628M	17M	-6.36B	-900M	-168M	1.03B	-502M	-1.02B	-821M
Pretax Income+	258M	-374M	-4.55B	-316M	675M	2.35B	1.43B	1.09B	1.27B
Pretax Margin %	0.02%	-0.03%	-0.32%	-0.02%	0.05%	0.15%	0.08%	0.06%	0.08%
Income Tax+	-270M	-2.94B	408M	-46M	-81M	524M	210M	152M	412M
Effective Tax Rate %	1.95%	-6.78%	1.1%	3.03%	1.01%	0.75%	0.8%	0.67%	0.71%
Net Income+	503M	2.53B	-4.99B	-959M	681M	1.76B	1.15B	735M	907M
Net Margin %	0.04%	0.18%	-0.35%	-0.07%	0.05%	0.11%	0.07%	0.04%	0.05%
Net Income Growth %	-	4.04%	-2.97%	0.81%	1.71%	1.58%	-0.35%	-0.36%	0.23%
Net Income (Continuing)	528M	2.57B	-6.78B	-270M	756M	1.82B	1.22B	941M	863M
Discontinued Operations	0	0	0	-671M	-55M	-53M	-58M	-194M	56M
Minority Interest	198M	172M	265M	246M	239M	239M	239M	242M	241M
EPS (Diluted)+	0.58	2.92	-5.75	0.00	0.00	0.00	0.00	0.84	1.30
EPS Growth %	-	4.03%	-2.97%	1%	-	-	-	-	0.55%
EPS (Basic)	0.58	2.92	-5.75	0.00	0.00	0.00	0.00	0.84	1.31
Diluted Shares Outstanding	867.81M	867.81M	867.81M	0	0	0	0	867.81M	867.81M
Basic Shares Outstanding	867.81M	867.81M	867.81M	0	0	0	0	867.81M	867.81M
Dividend Payout Ratio	2.65%	0.39%	-	-	0.57%	0.23%	0.36%	0.6%	0.5%

Balance Sheet

	Dec 2016	Dec 2017	Dec 2018	Dec 2019	Dec 2020	Dec 2021	Dec 2022	Dec 2023	Dec 2024
Total Current Assets+	17.51B	23.05B	13.84B	13.52B	14.77B	15.55B	16.8B	16.26B	15.1B
Cash & Short-Term Investments	5.91B	8.76B	2.13B	1.77B	3.79B	4.54B	3.31B	2.74B	3.17B
Cash Only	4.55B	7.81B	2.13B	1.76B	3.53B	4.46B	3.19B	2.64B	3.11B
Short-Term Investments	1.36B	952M	5M	5M	269M	86M	124M	98M	63M
Accounts Receivable	4.96B	5.24B	5.26B	5.53B	4.93B	4.81B	5.7B	5.49B	5.68B
Days Sales Outstanding	128.91	134.29	134.38	145.73	126.47	112.17	119.21	116.28	122.53
Inventory	5.35B	8.63B	5.25B	5.03B	4.88B	5.18B	6.81B	6.9B	5.43B
Days Inventory Outstanding	232.72	375.04	224.89	214.19	209.47	205.07	238.22	253.84	208.07
Other Current Assets	788M	423M	9.41B	1.19B	1.17B	1.01B	968M	1.13B	820M
Total Non-Current Assets+	22.45B	89.91B	29.04B	28.88B	27.88B	26.8B	25.82B	26.74B	25.73B
Property, Plant & Equipment	8.85B	12.44B	4.53B	4.55B	4.4B	4.33B	4.25B	4.29B	4.1B
Fixed Asset Turnover	1.59x	1.15x	3.15x	3.05x	3.23x	3.62x	4.10x	4.02x	4.12x
Goodwill	4.17B	45.59B	10.19B	10.23B	10.27B	10.11B	9.96B	10.61B	10.41B
Intangible Assets	0	27.73B	12.05B	11.42B	10.75B	10.04B	9.34B	9.63B	8.88B
Long-Term Investments	649M	1.59B	138M	66M	66M	76M	102M	115M	134M
Other Non-Current Assets	5.47B	2.08B	1.83B	2.33B	1.94B	1.8B	1.69B	1.52B	1.81B
Total Assets+	39.96B	112.96B	42.88B	42.4B	42.65B	42.34B	42.62B	43B	40.83B
Asset Turnover	0.35x	0.13x	0.33x	0.33x	0.33x	0.37x	0.41x	0.40x	0.41x
Asset Growth %	-	1.83%	-0.62%	-0.01%	0.01%	-0.01%	0.01%	0.01%	-0.05%
Total Current Liabilities+	8.93B	12.14B	9.99B	8.24B	8.55B	9.56B	10.74B	10.41B	10.39B
Accounts Payable	3.68B	4.83B	3.8B	3.7B	3.62B	4.13B	4.89B	4.28B	4.04B
Days Payables Outstanding	159.99	209.87	162.69	157.58	155.1	163.34	171.2	157.48	154.71
Short-Term Debt	429M	2.78B	2.13B	3M	3M	17M	23M	197M	750M
Deferred Revenue (Current)	1000K	1000K	1000K	1000K	1000K	1000K	1000K	1000K	1000K
Other Current Liabilities	2.61B	2.52B	985M	-2.58B	-1M	0	0	0	0
Current Ratio	1.96x	1.90x	1.38x	1.64x	1.73x	1.63x	1.56x	1.56x	1.45x
Quick Ratio	1.36x	1.19x	0.86x	1.03x	1.16x	1.08x	0.93x	0.90x	0.93x
Cash Conversion Cycle	201.64	299.45	196.58	202.34	180.83	153.9	186.23	212.65	175.89
Total Non-Current Liabilities+	20.84B	25.89B	9.06B	9.6B	9.04B	7.16B	6.33B	7.31B	6.41B
Long-Term Debt	8.1B	10.29B	5.72B	115M	1.1B	1.1B	1.28B	2.29B	1.95B
Capital Lease Obligations	9M	4M	67M	5M	0	3M	2M	0	0
Deferred Tax Liabilities	425M	5.84B	1.5B	920M	893M	1.22B	1.12B	899M	478M
Other Non-Current Liabilities	12.3B	9.71B	1.63B	8.56B	7.04B	4.84B	2.81B	4.12B	3.98B
Total Liabilities	29.77B	38.03B	19.06B	17.84B	17.59B	16.72B	17.08B	17.72B	16.8B
Total Debt+	8.54B	13.07B	2.07B	127M	1.11B	1.12B	1.31B	2.49B	2.7B
Net Debt	3.99B	5.26B	-60M	-1.64B	-2.42B	-3.34B	-1.88B	-155M	-403M
Debt / Equity	0.84x	0.17x	0.09x	0.01x	0.04x	0.04x	0.05x	0.10x	0.11x
Debt / EBITDA	3.98x	7.46x	0.94x	0.06x	0.55x	0.44x	0.41x	0.75x	0.81x
Net Debt / EBITDA	1.86x	3.00x	-0.03x	-0.75x	-1.20x	-1.30x	-0.60x	-0.05x	-0.12x
Interest Coverage	8.77x	2.54x	16.97x	4.29x	18.73x	43.90x	24.41x	9.06x	9.00x
Total Equity+	10.2B	74.93B	23.82B	24.55B	25.06B	25.62B	25.54B	25.28B	24.03B
Equity Growth %	-	6.35%	-0.68%	0.03%	0.02%	0.02%	-0%	-0.01%	-0.05%
Book Value per Share	11.75	86.35	27.45	999999.00	33.71	999999.00	999999.00	29.13	27.69
Total Shareholders' Equity	10B	74.76B	23.56B	24.31B	24.82B	25.38B	25.3B	25.04B	23.79B
Common Stock	285M	0	7M	7M	7M	7M	7M	7M	7M
Retained Earnings	14.92B	175M	-1M	-425M	0	524M	250M	-41M	55M
Treasury Stock	-6.73B	0	0	0	0	0	0	0	0
Accumulated OCI	-16.98B	-381M	-2.41B	-3.27B	-2.89B	-2.9B	-2.81B	-2.68B	-3.47B
Minority Interest	198M	172M	265M	246M	239M	239M	239M	242M	241M

Cash Flow

	Dec 2016	Dec 2017	Dec 2018	Dec 2019	Dec 2020	Dec 2021	Dec 2022	Dec 2023	Dec 2024
Cash from Operations+	3.36B	247M	483M	1.07B	2.06B	2.73B	872M	1.77B	2.15B
Operating CF Margin %	0.24%	0.02%	0.03%	0.08%	0.15%	0.17%	0.05%	0.1%	0.13%
Operating CF Growth %	-	-0.93%	0.96%	1.22%	0.93%	0.32%	-0.68%	1.03%	0.21%
Net Income	2.07B	2.71B	-5.03B	-941M	701M	1.82B	1.22B	924M	863M
Depreciation & Amortization	1.26B	1.56B	2.79B	1.6B	1.18B	1.24B	1.22B	1.21B	1.23B
Stock-Based Compensation	0	0	0	0	0	0	0	0	0
Deferred Taxes	0	-3.02B	31M	-477M	-330M	199M	-288M	-438M	-365M
Other Non-Cash Items	4.62B	4.7B	1.38B	1.33B	19M	-1.16B	286M	858M	500M
Working Capital Changes	-1.07B	-583M	-2.94B	-441M	497M	622M	-1.56B	-786M	-80M
Change in Receivables	-270M	-162M	-1.52B	-361M	187M	-113M	-993M	358M	-705M
Change in Inventory	-54M	-1.21B	-498M	74M	104M	-422M	-1.72B	57M	1.11B
Change in Payables	-674M	-621M	642M	149M	-118M	526M	807M	-663M	-115M
Cash from Investing+	-1.51B	386M	-505M	-904M	-674M	-362M	-632M	-1.99B	-589M
Capital Expenditures	-1.02B	-1.11B	-1.5B	-1.16B	-475M	-573M	-605M	-595M	-597M
CapEx % of Revenue	0.07%	0.08%	0.11%	0.08%	0.03%	0.04%	0.03%	0.03%	0.04%
Acquisitions	-	-	-	-	-	-	-	-	-
Investments	-	-	-	-	-	-	-	-	-
Other Investing	-340M	-214M	66M	236M	76M	74M	34M	23M	-27M
Cash from Financing+	-2.38B	2.4B	-2.62B	-2.93B	303M	-1.27B	-1.18B	-99M	-1.2B
Debt Issued (Net)	-	-	-	-	-	-	-	-	-
Equity Issued (Net)	-	-	-	-	-	-	-	-	-
Dividends Paid	-1.33B	-998M	-10M	-511M	-388M	-397M	-418M	-439M	-458M
Share Repurchases	-	-	-	-	-	-	-	-	-
Other Financing	-48M	-893M	0	5.28B	-32M	70M	33M	771M	28M
Net Change in Cash	-	-	-	-	-	-	-	-	-
Free Cash Flow+	2.34B	-866M	-1.02B	-93M	1.59B	2.15B	267M	1.17B	1.55B
FCF Margin %	0.17%	-0.06%	-0.07%	-0.01%	0.11%	0.14%	0.02%	0.07%	0.09%
FCF Growth %	-	-1.37%	-0.18%	0.91%	18.09%	0.36%	-0.88%	3.4%	0.32%
FCF per Share	2.69	-1.00	-1.17	-465000.00	2.14	999999.00	999999.00	1.35	1.78
FCF Conversion (FCF/Net Income)	6.67x	0.10x	-0.10x	-1.12x	3.03x	1.55x	0.76x	2.41x	2.36x
Interest Paid	0	0	923M	263M	36M	30M	75M	234M	244M
Taxes Paid	0	0	961M	234M	229M	341M	467M	535M	707M

Key Ratios

Metric	2016	2017	2018	2019	2020	2021	2022	2023	2024
Return on Equity (ROE)	4.93%	5.95%	-10.11%	-3.96%	2.74%	6.94%	4.48%	2.89%	3.68%
Return on Invested Capital (ROIC)	4.68%	0.3%	1.86%	1.88%	2.78%	4.4%	6.3%	6.49%	6.45%
Gross Margin	40.24%	41%	40.36%	38.07%	40.16%	41.11%	40.21%	42.41%	43.64%
Net Margin	3.58%	17.79%	-34.93%	-6.93%	4.79%	11.24%	6.57%	4.27%	5.36%
Debt / Equity	0.84x	0.17x	0.09x	0.01x	0.04x	0.04x	0.05x	0.10x	0.11x
Interest Coverage	8.77x	2.54x	16.97x	4.29x	18.73x	43.90x	24.41x	9.06x	9.00x
FCF Conversion	6.67x	0.10x	-0.10x	-1.12x	3.03x	1.55x	0.76x	2.41x	2.36x
Revenue Growth	-	1.42%	0.33%	-3.09%	2.68%	10.11%	11.5%	-1.31%	-1.85%

Revenue by Segment

	2012	2019	2020	2021	2022	2023	2024
Seed	-	7.59B	7.76B	8.4B	5.96B	6.45B	6.5B
Seed Growth	-	-	2.19%	8.33%	-29.12%	8.26%	0.76%
Crop Protection	-	6.26B	6.46B	7.25B	4.59B	4.03B	3.6B
Crop Protection Growth	-	-	3.28%	12.26%	-36.70%	-12.13%	-10.78%
Pharmaceuticals	-	-	-	-	-	-	-
Pharmaceuticals Growth	-	-	-	-	-	-	-

Revenue by Geography

	2012	2019	2020	2021	2022	2023	2024
Seed	-	-	-	-	5.96B	6.45B	6.5B
Seed Growth	-	-	-	-	-	8.26%	0.76%
Latin America	4.55B	2.89B	2.81B	3.54B	-	-	-
Latin America Growth	-	-36.46%	-2.91%	26.38%	-	-	-
EMEA	-	2.74B	2.84B	3.12B	-	-	-
EMEA Growth	-	-	3.72%	9.89%	-	-	-
Asia Pacific	8.03B	1.29B	1.4B	1.45B	-	-	-
Asia Pacific Growth	-	-83.97%	8.85%	3.50%	-	-	-
UNITED STATES	-	6.25B	-	-	-	-	-
UNITED STATES Growth	-	-	-	-	-	-	-
CANADA	-	674M	-	-	-	-	-
CANADA Growth	-	-	-	-	-	-	-
United States	13.28B	-	-	-	-	-	-
United States Growth	-	-	-	-	-	-	-
Europe, Middle East, and Africa	8.03B	-	-	-	-	-	-
Europe, Middle East, and Africa Growth	-	-	-	-	-	-	-
Europe, Middle East, and Africa, Other	3.17B	-	-	-	-	-	-
Europe, Middle East, and Africa, Other Growth	-	-	-	-	-	-	-
China Hong Kong	2.94B	-	-	-	-	-	-
China Hong Kong Growth	-	-	-	-	-	-	-
Brazil	2.36B	-	-	-	-	-	-
Brazil Growth	-	-	-	-	-	-	-
Japan	1.58B	-	-	-	-	-	-
Japan Growth	-	-	-	-	-	-	-
Germany	1.31B	-	-	-	-	-	-
Germany Growth	-	-	-	-	-	-	-
Mexico	1.05B	-	-	-	-	-	-
Mexico Growth	-	-	-	-	-	-	-
Canada	921M	-	-	-	-	-	-
Canada Growth	-	-	-	-	-	-	-
France	765M	-	-	-	-	-	-
France Growth	-	-	-	-	-	-	-
Italy	764M	-	-	-	-	-	-
Italy Growth	-	-	-	-	-	-	-
India	748M	-	-	-	-	-	-
India Growth	-	-	-	-	-	-	-
Latin America, Other	731M	-	-	-	-	-	-
Latin America, Other Growth	-	-	-	-	-	-	-
Asia Pacific, Other	666M	-	-	-	-	-	-
Asia Pacific, Other Growth	-	-	-	-	-	-	-
Korea	662M	-	-	-	-	-	-
Korea Growth	-	-	-	-	-	-	-
Taiwan	594M	-	-	-	-	-	-
Taiwan Growth	-	-	-	-	-	-	-
Argentina	406M	-	-	-	-	-	-
Argentina Growth	-	-	-	-	-	-	-
Russia	376M	-	-	-	-	-	-
Russia Growth	-	-	-	-	-	-	-
Spain	326M	-	-	-	-	-	-
Spain Growth	-	-	-	-	-	-	-
Thailand	324M	-	-	-	-	-	-
Thailand Growth	-	-	-	-	-	-	-
The Netherlands	312M	-	-	-	-	-	-
The Netherlands Growth	-	-	-	-	-	-	-
Australia	261M	-	-	-	-	-	-
Australia Growth	-	-	-	-	-	-	-
Belgium	217M	-	-	-	-	-	-
Belgium Growth	-	-	-	-	-	-	-
Singapore	147M	-	-	-	-	-	-
Singapore Growth	-	-	-	-	-	-	-
Malaysia	110M	-	-	-	-	-	-
Malaysia Growth	-	-	-	-	-	-	-
Denmark	95M	-	-	-	-	-	-
Denmark Growth	-	-	-	-	-	-	-
Luxembourg	77M	-	-	-	-	-	-
Luxembourg Growth	-	-	-	-	-	-	-

Frequently Asked Questions

Valuation & Price

EIDP, Inc. (CTA-PA) has a price-to-earnings (P/E) ratio of 42.0x. This suggests investors expect higher future growth.

Growth & Financials

EIDP, Inc. (CTA-PA) reported $17.47B in revenue for fiscal year 2024. This represents a 24% increase from $14.04B in 2016.

EIDP, Inc. (CTA-PA) saw revenue decline by 1.8% over the past year.

Yes, EIDP, Inc. (CTA-PA) is profitable, generating $1.61B in net income for fiscal year 2024 (5.4% net margin).

Dividend & Returns

Yes, EIDP, Inc. (CTA-PA) pays a dividend with a yield of 0.97%. This makes it attractive for income-focused investors.

EIDP, Inc. (CTA-PA) has a return on equity (ROE) of 3.7%. This is below average, suggesting room for improvement.

EIDP, Inc. (CTA-PA) generated $3.80B in free cash flow for fiscal year 2024. Positive FCF indicates the company can fund dividends, buybacks, or reinvestment.